Montefiore Medical Cancer Center
Welcome,         Profile    Billing    Logout  
 14 Trials 
6 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lee, Alice
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( )

Recruiting
3
1000
Europe, Canada, US, RoW
IVA337, Lanifibranor, Placebo
Inventiva Pharma
NASH - Nonalcoholic Steatohepatitis
09/25
09/26
AOST-2121, NCT04974008: Osteosarcoma Maintenance Therapy With OST31-164

Completed
2
39
US
OST31-164
George Clinical Pty Ltd
Bone Cancer
09/23
09/23
NCT06233903: 18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System

Not yet recruiting
2
29
US
18F-mFBG, Florbenguane F-18
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC), Albert Einstein College of Medicine
Neuroblastoma, Pheochromocytoma, Paraganglioma
12/24
03/25
IMPACT, NCT05989711: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH) ( Trial)

Recruiting
2
190
US, RoW
Pemvidutide, Placebo
Altimmune, Inc.
Non-Alcoholic Steatohepatitis (NASH)
02/25
09/25
Bayne, Ashley
MPNST, NCT04917042: Tazemetostat in Malignant Peripheral Nerve Sheath Tumors

Recruiting
2
24
US
Tazemetostat, TAZVERIK
University of Florida, Epizyme, Inc.
Peripheral Nerve Sheath Tumor
09/25
09/25
Zylber, Rebecca
AOST-2121, NCT04974008: Osteosarcoma Maintenance Therapy With OST31-164

Completed
2
39
US
OST31-164
George Clinical Pty Ltd
Bone Cancer
09/23
09/23

Download Options